Cargando…

Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling

BACKGROUND: Chemoresistance often causes the failure of treatment and death of patients with advanced non-small-cell lung cancer. However, there is still no resistance genes signature and available enriched signaling derived from a comprehensive RNA-Seq data analysis of lung cancer patients that cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yujia, Qiu, Fengjun, Ye, Tingjie, Lee, Sau Har, Xu, Jiatuo, Jia, Lingyan, Zeng, Rui, Wang, Xiaoling, Hu, Xudong, Yan, Xiaofeng, Li, Hua, Lu, Yanlin, Jiang, Rilei, Xu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102725/
https://www.ncbi.nlm.nih.gov/pubmed/35551652
http://dx.doi.org/10.1186/s13287-022-02859-3
_version_ 1784707396126375936
author Zhang, Yujia
Qiu, Fengjun
Ye, Tingjie
Lee, Sau Har
Xu, Jiatuo
Jia, Lingyan
Zeng, Rui
Wang, Xiaoling
Hu, Xudong
Yan, Xiaofeng
Li, Hua
Lu, Yanlin
Wang, Xiaoling
Jiang, Rilei
Xu, Wei
author_facet Zhang, Yujia
Qiu, Fengjun
Ye, Tingjie
Lee, Sau Har
Xu, Jiatuo
Jia, Lingyan
Zeng, Rui
Wang, Xiaoling
Hu, Xudong
Yan, Xiaofeng
Li, Hua
Lu, Yanlin
Wang, Xiaoling
Jiang, Rilei
Xu, Wei
author_sort Zhang, Yujia
collection PubMed
description BACKGROUND: Chemoresistance often causes the failure of treatment and death of patients with advanced non-small-cell lung cancer. However, there is still no resistance genes signature and available enriched signaling derived from a comprehensive RNA-Seq data analysis of lung cancer patients that could act as a therapeutic target to re-sensitize the acquired resistant cancer cells to chemo-drugs. Hence, in this study, we aimed to identify the resistance signature for clinical lung cancer patients and explore the regulatory mechanism. METHOD: Analysis of RNA-Seq data from clinical lung cancer patients was conducted in R studio to identify the resistance signature. The resistance signature was validated by survival time of lung cancer patients and qPCR in chemo-resistant cells. Cytokine application, small-interfering RNA and pharmacological inhibition approaches were applied to characterize the function and molecular mechanism of EREG and downstream signaling in chemoresistance regulation via stemness. RESULTS: The RTK and vitamin D signaling were enriched among resistance genes, where 6 genes were validated as resistance signature and associated with poor survival in patients. EREG/ERK signaling was activated by chemo-drugs in NSCLC cells. EREG protein promoted the NSCLC resistance to chemo-drugs by increasing stemness genes expression. Additionally, inhibition of EREG/ErbB had downregulated ERK signaling, resulting in decreased expression of stemness-associated genes and subsequently re-sensitized the resistant NSCLC cells and spheres to chemo-drugs. CONCLUSIONS: These findings revealed 6 resistance genes signature and proved that EREG/ErbB regulated the stemness to maintain chemoresistance of NSCLC via ERK signaling. Therefore, targeting EREG/ErbB might significantly and effectively resolve the chemoresistance issue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02859-3.
format Online
Article
Text
id pubmed-9102725
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91027252022-05-14 Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling Zhang, Yujia Qiu, Fengjun Ye, Tingjie Lee, Sau Har Xu, Jiatuo Jia, Lingyan Zeng, Rui Wang, Xiaoling Hu, Xudong Yan, Xiaofeng Li, Hua Lu, Yanlin Wang, Xiaoling Jiang, Rilei Xu, Wei Stem Cell Res Ther Research BACKGROUND: Chemoresistance often causes the failure of treatment and death of patients with advanced non-small-cell lung cancer. However, there is still no resistance genes signature and available enriched signaling derived from a comprehensive RNA-Seq data analysis of lung cancer patients that could act as a therapeutic target to re-sensitize the acquired resistant cancer cells to chemo-drugs. Hence, in this study, we aimed to identify the resistance signature for clinical lung cancer patients and explore the regulatory mechanism. METHOD: Analysis of RNA-Seq data from clinical lung cancer patients was conducted in R studio to identify the resistance signature. The resistance signature was validated by survival time of lung cancer patients and qPCR in chemo-resistant cells. Cytokine application, small-interfering RNA and pharmacological inhibition approaches were applied to characterize the function and molecular mechanism of EREG and downstream signaling in chemoresistance regulation via stemness. RESULTS: The RTK and vitamin D signaling were enriched among resistance genes, where 6 genes were validated as resistance signature and associated with poor survival in patients. EREG/ERK signaling was activated by chemo-drugs in NSCLC cells. EREG protein promoted the NSCLC resistance to chemo-drugs by increasing stemness genes expression. Additionally, inhibition of EREG/ErbB had downregulated ERK signaling, resulting in decreased expression of stemness-associated genes and subsequently re-sensitized the resistant NSCLC cells and spheres to chemo-drugs. CONCLUSIONS: These findings revealed 6 resistance genes signature and proved that EREG/ErbB regulated the stemness to maintain chemoresistance of NSCLC via ERK signaling. Therefore, targeting EREG/ErbB might significantly and effectively resolve the chemoresistance issue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02859-3. BioMed Central 2022-05-12 /pmc/articles/PMC9102725/ /pubmed/35551652 http://dx.doi.org/10.1186/s13287-022-02859-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Yujia
Qiu, Fengjun
Ye, Tingjie
Lee, Sau Har
Xu, Jiatuo
Jia, Lingyan
Zeng, Rui
Wang, Xiaoling
Hu, Xudong
Yan, Xiaofeng
Li, Hua
Lu, Yanlin
Wang, Xiaoling
Jiang, Rilei
Xu, Wei
Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
title Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
title_full Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
title_fullStr Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
title_full_unstemmed Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
title_short Epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via ERK signaling
title_sort epiregulin increases stemness-associated genes expression and promotes chemoresistance of non-small cell lung cancer via erk signaling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102725/
https://www.ncbi.nlm.nih.gov/pubmed/35551652
http://dx.doi.org/10.1186/s13287-022-02859-3
work_keys_str_mv AT zhangyujia epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT qiufengjun epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT yetingjie epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT leesauhar epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT xujiatuo epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT jialingyan epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT zengrui epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT wangxiaoling epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT huxudong epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT yanxiaofeng epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT lihua epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT luyanlin epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT wangxiaoling epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT jiangrilei epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling
AT xuwei epiregulinincreasesstemnessassociatedgenesexpressionandpromoteschemoresistanceofnonsmallcelllungcancerviaerksignaling